Human immunoglobulin (Sichuan Yuanda Shuyang Pharmaceutical)

人免疫球蛋白（四川远大蜀阳药业）

Report date: 2024/09/24 09:43:04

Base Information

Drug NameHuman immunoglobulin (Sichuan Yuanda Shuyang Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsImmunologic Deficiency SyndromesUrticariaDermatitis, Allergic Contact +[5] 
Global Approved IndicationsUrticariaDermatitis, Allergic ContactAsthma
Approved Indications in ChinaUrticariaDermatitis, Allergic ContactAsthma
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesYuanda Shuyang Life Sciences (Chengdu) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYuanda Shuyang Life Sciences (Chengdu) Co Ltd
Inactive CompaniesN/A
Active IndicationsImmunologic Deficiency SyndromesUrticariaDermatitis, Allergic Contact +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA01
Related LinksN/A